News
7d
Health and Me on MSNUnexpected Sign Of Lung Conditions Can Be Hidden Right At Your FingertipsEarly signs of illnesses can often show up in unexpected places. Being able to identify them can help you get proper and ...
Cystic fibrosis (CF) is a rare autosomal recessive disorder that affects numerous systems of the body. It is a complicated ...
At 7 years old, Morgan Barrett was diagnosed with cystic fibrosis. Prior to her diagnosis, she struggled to gain weight ...
Cystic fibrosis (CF) is a rare autosomal recessive disorder that affects numerous systems of the body. It is a complicated ...
Cystic fibrosis represents one of the most common inherited genetic disorders affecting people of European descent, touching the lives of approximately 30,000 individuals in the United States alone.
Cystic fibrosis transmembrane conductance regulator (CFTR), a Cl−-ion channel, assembles into dynamic macromolecular complexes. Understanding how these complexes regulate the intracellular ...
Cystic fibrosis (CF) is one of the most common inherited diseases in white Americans—occurring in 1 in every 4,855 births—but mounting evidence suggests that the disease is more common in ...
A look at how cystic fibrosis has become more treatable with a doctor who has studied it for 50 years. And a new folk art museum opens in the Amana Colonies.
RALEIGH, N.C. — When he was about 14, Pete Proimos learned a soul-crushing statistic about the cystic fibrosis he’d endured since birth: Patients back then didn’t live much past high school.
Sionna Therapeutics, Inc. has announced the presentation of promising preclinical data at the 48th European Cystic Fibrosis Conference in Milan, showing that its nucleotide-binding domain 1 (NBD1 ...
Boehringer Ingelheim (BI) and the UK Cystic Fibrosis Gene Therapy Consortium announced a global collaboration to develop a first-in-class, long-term therapy for patients with cystic fibrosis (CF ...
Sionna plans to advance SION-719 to a Phase 2a proof-of-concept add-on to standard of care trial in cystic fibrosis patients, and SION-451 to a Phase 1 healthy volunteer dual combination trial .
Some results have been hidden because they may be inaccessible to you
Show inaccessible results